Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Apply
CD22 CAR T-Cell
CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step